Flagship Pioneering Inc. Syros Pharmaceuticals, Inc. Transaction History

Flagship Pioneering Inc.

  • $837 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$7.14 - $11.65 $1.9 Million - $3.1 Million
-265,943 Reduced 8.3%
2,938,494 $30.5 Million
Q3 2017

Nov 03, 2017
BUY
$13.52 - $23.75 $43.3 Million - $76.1 Million
3,204,437
3,204,437 $47.2 Million

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Flagship Pioneering Inc. Portfolio

Follow Flagship Pioneering Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flagship Pioneering Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email